Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

1.580 +0.040 (+2.60%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 184,359
Open 1.560
Bid (Size) 1.550 (100)
Ask (Size) 1.600 (1,500)
Prev. Close 1.540
Today's Range 1.540 - 1.600
52wk Range 1.170 - 8.080
Shares Outstanding 19,996,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire

Performance

YTD
-7.1%
-7.1%
1 Month
-14.1%
-14.1%
3 Month
-13.7%
-13.7%
6 Month
-72.1%
-72.1%
1 Year
-30.4%
-30.4%

More News

Read More
News headline image
BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients ↗
Via Benzinga
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study ↗
Via Stocktwits
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later ↗
Via Stocktwits
BioXcel Sparks Retail Frenzy As Stock Soars Ahead Of Phase 3 Results For Bipolar, Schizophrenia Drug ↗
Via Stocktwits
BioXcel Stock In Focus: FDA Issues Positive Early Feedback Ahead Of Key Meeting On Expanded Psychiatric Label ↗
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank? ↗
Via Benzinga
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Wednesday? ↗
Via Chartmill
News headline image
BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment ↗
Via Benzinga
News headline image
The market is filled with gapping stocks in Wednesday's session. ↗
Via Chartmill
News headline image
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
News headline image
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
Via AB Newswire
Topics Artificial Intelligence
News headline image
BioXcel Therapeutics (BTAI) Stock Is Surging Monday: What's Going On? ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
BioXcel Stock In Focus: FDA Issues Positive Early Feedback Ahead Of Key Meeting On Expanded Psychiatric Label (This works) ↗
Via Stocktwits

Frequently Asked Questions

Is BioXcel Therapeutics, Inc. - Common Stock publicly traded?
Yes, BioXcel Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does BioXcel Therapeutics, Inc. - Common Stock trade on?
BioXcel Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioXcel Therapeutics, Inc. - Common Stock?
The ticker symbol for BioXcel Therapeutics, Inc. - Common Stock is BTAI on the Nasdaq Stock Market
What is the current price of BioXcel Therapeutics, Inc. - Common Stock?
The current price of BioXcel Therapeutics, Inc. - Common Stock is 1.580
When was BioXcel Therapeutics, Inc. - Common Stock last traded?
The last trade of BioXcel Therapeutics, Inc. - Common Stock was at 02/13/26 04:00 PM ET
What is the market capitalization of BioXcel Therapeutics, Inc. - Common Stock?
The market capitalization of BioXcel Therapeutics, Inc. - Common Stock is 31.59M
How many shares of BioXcel Therapeutics, Inc. - Common Stock are outstanding?
BioXcel Therapeutics, Inc. - Common Stock has 32M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.